Patient Characteristics
A total of 24 (10.5%) patients developed CSVT during treatment, of
those 9 (37.5%) were during the induction phase of treatment and 15
(62.5%) during reinduction phases (Reinduction 1 or Reinduction2).
Clinical features of all patients are summarized in Table 1.